skip to main content

The Safer Prescription of Opioids Tool (SPOT) — a novel clinical decision support digital health platform for opioid conversion in palliative and end-of-life care: a single centre pilot study

Flint, Roger ; Jamieson, Scott ; Buchanan, Dean ; Botros, S ; Forbes, Joanna ; Cuschieri, Alfred ; George, J

British journal of general practice, 2019-06, Vol.69 (suppl 1), p.bjgp19X703265 [Peer Reviewed Journal]

Full text available

Citations Cited by
  • Title:
    The Safer Prescription of Opioids Tool (SPOT) — a novel clinical decision support digital health platform for opioid conversion in palliative and end-of-life care: a single centre pilot study
  • Author: Flint, Roger ; Jamieson, Scott ; Buchanan, Dean ; Botros, S ; Forbes, Joanna ; Cuschieri, Alfred ; George, J
  • Is Part Of: British journal of general practice, 2019-06, Vol.69 (suppl 1), p.bjgp19X703265
  • Description: BackgroundOpioid conversion is complex and currently performed manually using tables of approximate equivalence, often in high pressure clinical situations. Apps that offer opioid dose conversion are available but there are concerns about their accuracy, reliability, and clinical validation.AimThe study evaluated a novel opioid dose conversion app, The Safer Prescription of Opioids Tool (SPOT), as a clinician decision support (CDS) platform. The secondary objective was to use SPOT to describe patterns of opioid dose conversion in palliative and end-of-life care.MethodThis prospective clinical utility single-centre pilot study followed a mixed methods design. Prescribers completed an initial survey exploring their current opioid prescribing practice. Thereafter prescribers used SPOT for opioid dosage conversions in parallel to their usual clinical practice. Lastly, prescribers evaluated SPOT through a survey and focus group. SPOT was evaluated using clinical data across primary, secondary and tertiary care in palliative care and end of life care settings at a Scottish Health Board in both out-of-hours and in-hours.ResultsSPOT correctly matched the Gold Standard result in 258 of 268 (96.3%) calculations. Users had a statistically significant increase in confidence in prescribing opioids after using SPOT. A majority (62%) of conversions were for cancer pain. Focus group feedback highlighted perceived benefits in Quality Improvement and Safety when using SPOT.ConclusionSPOT is a safe, reliable and validated CDS that has significant potential to reduce harms from opioid dosing errors, particularly in primary care, including rural primary care, and the out-of-hours setting.
  • Language: English
  • Identifier: ISSN: 0960-1643
    EISSN: 1478-5242
    DOI: 10.3399/bjgp19X703265

Searching Remote Databases, Please Wait